Skip to main content
Premium Trial:

Request an Annual Quote

NHGRI Earmarks Portion of Sequencing Capacity for Medical Sequencing Efforts

NEW YORK, Oct. 17 (GenomeWeb News) - The National Human Genome Research Institute said today that it will devote a portion of its large-scale sequencing capacity to medical sequencing efforts focused on identifying the genetic causes of specific diseases.

 

According to the NHGRI, the highest priority projects will be those involving "large-scale sequencing over the next few years to identify the genes responsible for dozens of relatively rare, single-gene diseases; [sequencing of] all of the genes on the X chromosome from affected individuals to identify those involved in sex-linked diseases; and [surveying] the range of variants in genes known to contribute to some common diseases."

 

The NHGRI added that "the launch of each project will depend on a number of factors, including the strategic selection of specific diseases and the availability of patient samples with appropriate informed consent."

 

However, the first project is expected to begin in the next 12 months and be a "demonstration project to find the genetic variations responsible for seven rare, autosomal Mendelian disorders," the institute said. This initial effort is expected to "establish the best procedures for obtaining quality samples, for determining the minimum number of affected and control samples needed, and for deciding how the data will be released to the biomedical research community."

 

Additional information can be found on the NHGRI's website here.

 

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.